CY1113127T1 - Οξα στεροειδη παραγωγα ως εκλεκτικοι τροποποιητες υποδοχεων προγεστερονης - Google Patents

Οξα στεροειδη παραγωγα ως εκλεκτικοι τροποποιητες υποδοχεων προγεστερονης

Info

Publication number
CY1113127T1
CY1113127T1 CY20121100858T CY121100858T CY1113127T1 CY 1113127 T1 CY1113127 T1 CY 1113127T1 CY 20121100858 T CY20121100858 T CY 20121100858T CY 121100858 T CY121100858 T CY 121100858T CY 1113127 T1 CY1113127 T1 CY 1113127T1
Authority
CY
Cyprus
Prior art keywords
progesterone receptors
oxa
steroid products
extended models
oxa steroid
Prior art date
Application number
CY20121100858T
Other languages
English (en)
Inventor
Fu-An Kang
Nareshkumar F Jain
Zhihua Sui
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1113127T1 publication Critical patent/CY1113127T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Η παρούσα εφεύρεση απευθύνεται σε νέα παράγωγα 7-οξα-εστρα-4,9-διενο-3,17-διόνης, φαρμακευτικές συνθέσεις που τα περιέχουν και στη χρήση τους στην αντιμετώπιση των διαταραχών και των παθήσεων που διαμορφώνονται από τουλάχιστον μία προγεστερόνη ή έναν γλυκοκορτικοειδή υποδοχέα.
CY20121100858T 2006-02-17 2012-09-19 Οξα στεροειδη παραγωγα ως εκλεκτικοι τροποποιητες υποδοχεων προγεστερονης CY1113127T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77504206P 2006-02-17 2006-02-17
EP07757100A EP1991559B1 (en) 2006-02-17 2007-02-16 Oxa-steroids derivatives as selective progesterone receptor modulators

Publications (1)

Publication Number Publication Date
CY1113127T1 true CY1113127T1 (el) 2016-04-13

Family

ID=38438064

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100858T CY1113127T1 (el) 2006-02-17 2012-09-19 Οξα στεροειδη παραγωγα ως εκλεκτικοι τροποποιητες υποδοχεων προγεστερονης

Country Status (14)

Country Link
US (1) US7763648B2 (el)
EP (1) EP1991559B1 (el)
JP (1) JP2009527494A (el)
CN (1) CN101426806B (el)
AU (1) AU2007217101A1 (el)
CA (1) CA2642834C (el)
CY (1) CY1113127T1 (el)
DK (1) DK1991559T3 (el)
ES (1) ES2389113T3 (el)
HK (2) HK1125946A1 (el)
PL (1) PL1991559T3 (el)
PT (1) PT1991559E (el)
SI (1) SI1991559T1 (el)
WO (1) WO2007098388A2 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7981927B2 (en) 2007-03-07 2011-07-19 Janssen Pharmaceutica N.V. Steroids derivatives as selective progesterone receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962275A (en) * 1972-06-05 1976-06-08 Hoffmann-La Roche Inc. 7-oxa steroids
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained

Also Published As

Publication number Publication date
WO2007098388A3 (en) 2007-12-06
CN101426806A (zh) 2009-05-06
SI1991559T1 (sl) 2012-09-28
JP2009527494A (ja) 2009-07-30
US20070197635A1 (en) 2007-08-23
WO2007098388A2 (en) 2007-08-30
DK1991559T3 (da) 2012-10-08
EP1991559A2 (en) 2008-11-19
CA2642834A1 (en) 2007-08-30
ES2389113T3 (es) 2012-10-23
EP1991559B1 (en) 2012-06-27
HK1131787A1 (en) 2010-02-05
AU2007217101A1 (en) 2007-08-30
PL1991559T3 (pl) 2012-11-30
US7763648B2 (en) 2010-07-27
PT1991559E (pt) 2012-09-06
HK1125946A1 (en) 2009-08-21
CA2642834C (en) 2014-04-15
CN101426806B (zh) 2012-02-01

Similar Documents

Publication Publication Date Title
CY1113146T1 (el) 11-φωσφο-στεροειδη παραγωγα ως τροποποιητες του υποδοχεα προγεστερονης
CY1120297T1 (el) Ρυθμιστες υποδοχεα ανδρογονου και χρησεις αυτων
CY1111128T1 (el) Στεροειδη παραγωγα 17-φωσφορου χρησιμα ως τροποποιητες υποδοχεων προγεστερονης
GT200900175A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
CY1119661T1 (el) 17-υδροξυ-17-πενταφθοροαιθυλο-οιστρα-4,9(10)-διεν-11-αρυλο-παραγωγα, μεθοδοι για την παραγωγη αυτων και χρηση αυτων για την αγωγη παθησεων
CY1114872T1 (el) Συνθεσεις και μεθοδοι χρησης αντισωματων εναντι της σκληροστεϊνης
CR10243A (es) "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos"
EA200900202A1 (ru) Селективные модуляторы андрогенного рецептора, их аналоги и производные и их использование
MX2013002975A (es) Moduladores de receptores de estrogenos y usos de los mismos.
EA201270815A1 (ru) Модуляторы рецепторов эстрогена и их применение
DE602007006961D1 (de) Cgrp-rezeptorantagonisten
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
EA201071291A2 (ru) Nmda рецепторные антагонисты для лечения нейропсихиатрических расстройств
EA200970835A1 (ru) Индазолы, применяемые для лечения расстройств, опосредуемых эстрогеновым рецептором бета
UY30572A1 (es) N-(1-ftalazin-1-il-piperidin-4-il)-amidas como moduladores del receptor ep2
CY1118044T1 (el) Παρασκευασμα συνδυασμου με ανταγωνιστη και κορτικοστεροειδες
CR10497A (es) Derivados de piperazinilo utiles en el tratamiento de enfermedades mediadas por el receptor gpr38
ATE542795T1 (de) Benzylpiperazinderivate als motilin- rezeptorantagonisten
MX2023000677A (es) Compuestos moduladores de receptor de estrogeno.
SE0400346D0 (sv) Steroids for cancer treatment
MA32224B1 (fr) Derives de (pyrazolyl-carbonyl) imidazolidinone pour le traitement de maladies retrovirales
ECSP10010379A (es) Derivados de oxindol sustituido y su uso para el tratamiento de enfermedades dependientes de la vasopresina
BR112012014235A2 (pt) tiazóis bicíclicos como moduladores alostéricos de receptores mglur5
CY1121190T1 (el) Δοσολογικη μορφη ανταγωνιστη υποδοχεα προγεστερονης
CY1113127T1 (el) Οξα στεροειδη παραγωγα ως εκλεκτικοι τροποποιητες υποδοχεων προγεστερονης